Bis-(2-Chloroethyl)Methylamine Topical Formulation Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Bis-(2-chloroethyl)methylamine, a highly reactive alkylating agent used in treating skin disorders, is unstable in various media, particularly water, leading to limited stability and unpleasant formulations, necessitating frequent refrigeration and short storage times, which complicates patient use.

Innovation Solution

A pharmaceutical composition comprising bis-(2-chloroethyl)methylamine hydrochloride and 2-(2-ethoxy-ethoxy)-ethanol, with specific excipients, achieves stability for at least 90 days when stored at room temperature for up to 1 hour and refrigerated for the remainder of the day, even under conditions of humidity and light exposure.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If bis-(2-chloroethyl)methylamine is formulated as an aqueous solution or petrolatum-based ointment, then it can be applied topically to treat skin disorders, but it becomes unstable and requires frequent refrigeration with short storage times

Engineering Contradiction:
Improvetopical application convenienceVSAvoiddrug stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent uses a specific base (e.g., triethylamine, diethylisopropylamine) as an intermediary substance to stabilize the bis-(2-chloroethyl)methylamine hydrochloride in a greaseless topical formulation. The base forms a stable complex with the alkylating agent, preventing degradation while maintaining topical applicability. This resolves the contradiction by introducing a mediating substance that enables both stability and ease of operation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the pH and chemical environment parameters of the formulation by incorporating specific bases and buffering agents. This parameter modification stabilizes the bis-(2-chloroethyl)methylamine hydrochloride, extending storage time to at least 90 days at room temperature with refrigeration, thereby improving both stability and operational convenience without requiring frequent refrigeration.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If the composition is stored at room temperature for extended periods, then patient convenience is improved, but the drug degrades due to humidity and light exposure

Engineering Contradiction:
Improvestorage convenienceVSAvoiddrug integrity
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent employs stabilizing bases and antioxidants as intermediary substances that protect the bis-(2-chloroethyl)methylamine hydrochloride from degradation by humidity and light. These intermediaries form protective complexes or scavenging systems that maintain drug integrity during room temperature storage, enabling patients to store the medication conveniently without constant refrigeration while ensuring at least 90% drug remains active.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If greaseless formulation is used instead of petrolatum-based ointment, then patient comfort is improved, but formulation stability becomes more difficult to achieve

Engineering Contradiction:
Improvepatient comfortVSAvoidformulation stability
Core Design Contradiction:
Ease of operationVSEase of manufacture

Solution Approach 1:

The patent creates a composite greaseless formulation by combining bis-(2-chloroethyl)methylamine hydrochloride with specific bases (e.g., triethylamine), buffering agents, and antioxidants in a water-soluble or alcohol-based vehicle. This composite system provides both patient comfort (greaseless, non-sticky) and formulation stability (resistant to degradation), resolving the contradiction between comfort and manufacturability.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the formulation parameters by eliminating petrolatum and using alternative vehicles with different chemical properties. By adjusting pH, ionic strength, and incorporating chelating agents, the greaseless formulation achieves stability comparable to or better than traditional petrolatum-based formulations, while providing improved patient comfort and ease of application.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250281425A1Methods for treating skin disorders with a topical composition of bis-(2-chloroethyl)methylamine
Publication Date: 2025.09.11 HELSINN BIREX PHARMA
  • US20250281425A1 patent drawing

AI summary

Provided are methods for treating skin disorders comprising topically applying a highly stable pharmaceutical composition comprising bis-(2-chloroethyl)methylamine or a pharmaceutically acceptable salt thereof.